TITLE

Reasons for illicit drug use in people with schizophrenia: Qualitative study

AUTHOR(S)
Asher, Carolyn J.; Gask, Linda
PUB. DATE
January 2010
SOURCE
BMC Psychiatry;2010, Vol. 10, p94
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Drug misuse is an important clinical problem associated with a poorer outcome in patients who have a diagnosis of schizophrenia. Qualitative studies have rarely been used to elicit reasons for drug use in psychosis, but not in schizophrenia. Methods: Seventeen people with a diagnosis of schizophrenia and who had used street drugs were interviewed and asked to describe, in narrative form, their street drug use from their early experiences to the present day. Grounded theory was used to analyse the transcripts. Results: We identified five reasons for continuing street drug use. The reasons were: as an 'identity defining vocation', 'to belong to a peer group', due to 'hopelessness', because of 'beliefs about symptoms and how street drugs influence them' and viewing drugs as 'equivalent to taking psychotropic medication'. Street drugs were often used to reduce anxiety aroused by voice hearing. Some participants reported street drugs to focus their attention more on persecutory voices in the hope of outwitting their perceived persecutors. Conclusions: It would be clinically useful to examine for the presence of the five factors in patients who have a diagnosis of schizophrenia and use street drugs, as this is likely to help the clinician to tailor management of substance misuse to the individual patient's beliefs.
ACCESSION #
57221024

 

Related Articles

  • New drugs for schizophrenia.  // American Family Physician;9/15/1997, Vol. 56 Issue 4, p1159 

    Provides information and guide about drugs for schizophrenia. How people with schizophrenia think and act; Difference of the 1997 schizophrenia drugs with other drugs; Facts about schizophrenia drugs.

  • Treatment Guidelines for Patients with Schizophrenia or Psychotic Disorder who are Hospitalized in a Psychiatry Clinic. Alptekin, Koksal; Ucok, Alp; Ayer, Ahmet; Unal, Ahmet; Erol, Atila; Ensari, Hulya; Atmaca, Murad; Ozguven, Halise Devrimci // Klinik Psikofarmakoloji Bulteni;2014, Vol. 24 Issue 3, p276 

    In schizophrenia, hospitalization is generally indicated for patients who pose a serious threat to themselves or others, those who are disorganized to the extent of not to being able to look after themselves or who are experiencing delusions/hallucinations. The steps to be taken during the time...

  • Active and Passive Avoidance Learning in Controls and Schizophrenic Patients on Racemic Propranolol and Neuroleptics. Gruzelier, John; Thornton, Susan; Staniforth, David; Zaki, Saniha; Yorkston, Neil // British Journal of Psychiatry;Aug80, Vol. 137, p131 

    Normal controls and schizophrenic patients on propranolol as sole drug or combined with neuroleptics showed superior active and passive avoidance learning to schizophrenic patients who were medicated with conventional neuroleptics only. Active avoidance involved responding quickly, passive...

  • PSYCHOSOCIAL APPROACHES IN OUTPATIENTS WITH SCHIZOPHRENIA. Do&gcaron;an, Selma; Do&gcaron;an, Orhan; Tel, Havva; Çoker, Fatma; Polatöz, Özden; Do&gcaron;an, Filiz B. // Psychiatric Rehabilitation Journal;Winter2004, Vol. 27 Issue 3, p279 

    The objective of this study was to determine how psychosocial approaches to people with schizophrenia, in addition to treatment with psychotropic drugs, affect the course of the illness and family interactions. The project included people who were diagnosed with schizophrenia and hospitalized at...

  • Comparison of Antipsychotic Depot Injections in the Maintenance Treatment of Schizophrenia. Carney, M. W. P.; Sheffield, B. F. // British Journal of Psychiatry;Nov76, Vol. 129, p476 

    Summary. 122 Schizophrenic patients treated with injections of fluphenazine ethanate, 97 with fluphenazine decanoate and 199 with flupenthixol decanoate were followed up for mean times of 41, 33 and 21 months respectively. Their progress was compared by examining reasons for discontinuing...

  • Paliperidone ER Prevents Symptom Recurrence in Schizophrenia.  // Journal of Psychosocial Nursing & Mental Health Services;Sep2006, Vol. 44 Issue 9, p36 

    The article discusses research being done on the use of Paliperidone ER for preventing the recurrence in schizophrenia. It references a study published on July 12, 2006. Based on the study, Paliperidone ER drugs demonstrated long-term stability in schizophrenic patients. Other findings of the...

  • From generation of biomarkers to treatment and psychosocial aspects of psychosis. Falkai, P.; Möller, H.-J. // European Archives of Psychiatry & Clinical Neuroscience;Oct2011, Vol. 261 Issue 7, p457 

    No abstract available.

  • Researchers Focus on Recovery in Schizophrenia. Friedrich, M. J. // JAMA: Journal of the American Medical Association;7/2/2014, Vol. 312 Issue 1, p16 

    The article discusses modern approaches to managing schizophrenia to help patients attain more normal function. Topics covered include the recommendations of the report "Schizophrenia: Time to Commit to Policy Change," by Stephen Marder et al, a study on the characteristics of people with...

  • Lithium Treatment in Schizophrenia and Schizo-Affective Disorders. Delva, N. J.; Letemendia, F. J. J. // British Journal of Psychiatry;Oct82, Vol. 141, p387 

    Between one third and one half of schizophrenic patients appear to benefit from treatment with lithium carbonate. An even higher proportion of schizo-affective patients benefit, some showing complete recovery. Current unfavourable views on the use of lithium in schizophrenia are contested....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics